Cargando…
Advances in GLP-1 treatment: focus on oral semaglutide
BACKGROUND: There is currently a large arsenal of antidiabetic drugs available to treat type 2 diabetes (T2D). However, this is a serious chronic disease that affects millions of adults worldwide and is responsible for severe complications, comorbidities, and low quality of life when uncontrolled du...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442336/ https://www.ncbi.nlm.nih.gov/pubmed/34526121 http://dx.doi.org/10.1186/s13098-021-00713-9 |